177 related articles for article (PubMed ID: 22287720)
21. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
[TBL] [Abstract][Full Text] [Related]
22. Modulation of macrophage differentiation and activation by decoy receptor 3.
Chang YC; Hsu TL; Lin HH; Chio CC; Chiu AW; Chen NJ; Lin CH; Hsieh SL
J Leukoc Biol; 2004 Mar; 75(3):486-94. PubMed ID: 14657214
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
Zhang Y; Sime W; Juhas M; Sjölander A
Eur J Cancer; 2013 Oct; 49(15):3320-34. PubMed ID: 23810249
[TBL] [Abstract][Full Text] [Related]
24. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
[TBL] [Abstract][Full Text] [Related]
25. IL-10 acts as a developmental switch guiding monocyte differentiation to macrophages during a murine peritoneal infection.
Nguyen HH; Tran BT; Muller W; Jack RS
J Immunol; 2012 Sep; 189(6):3112-20. PubMed ID: 22869902
[TBL] [Abstract][Full Text] [Related]
26. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
Front Immunol; 2022; 13():879648. PubMed ID: 35720343
[TBL] [Abstract][Full Text] [Related]
27. Role of prognostic biomarker decoy receptor 3 and immunomodulation in kidney diseases.
Weng SC; Tarng DC
J Chin Med Assoc; 2019 Sep; 82(9):680-684. PubMed ID: 31356560
[TBL] [Abstract][Full Text] [Related]
28. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
29. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
30. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
31. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells.
Chen SJ; Wang YL; Kao JH; Wu SF; Lo WT; Wu CC; Tao PL; Wang CC; Chang DM; Sytwu HK
Mol Immunol; 2009 Dec; 47(2-3):567-74. PubMed ID: 19819554
[TBL] [Abstract][Full Text] [Related]
32. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice.
Ka SM; Sytwu HK; Chang DM; Hsieh SL; Tsai PY; Chen A
J Am Soc Nephrol; 2007 Sep; 18(9):2473-85. PubMed ID: 17687076
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
34. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
35. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program.
Goldmann O; von Köckritz-Blickwede M; Höltje C; Chhatwal GS; Geffers R; Medina E
Infect Immun; 2007 Aug; 75(8):4148-57. PubMed ID: 17526748
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
[TBL] [Abstract][Full Text] [Related]
39. Nodal promotes the generation of M2-like macrophages and downregulates the expression of IL-12.
Wang XF; Wang HS; Zhang F; Guo Q; Wang H; Wang KF; Zhang G; Bu XZ; Cai SH; Du J
Eur J Immunol; 2014 Jan; 44(1):173-83. PubMed ID: 24114072
[TBL] [Abstract][Full Text] [Related]
40. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha.
Jüttner S; Bernhagen J; Metz CN; Röllinghoff M; Bucala R; Gessner A
J Immunol; 1998 Sep; 161(5):2383-90. PubMed ID: 9725234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]